News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Nolan Garry Ph.D.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/05/2023 |
4
| Nolan Garry Ph.D. (Director) has filed a Form 4 on Akoya Biosciences, Inc.|
Txns:
| Granted 56,322 options to buy
@ $5.7, valued at
$321k
|
|
| 03/27/2023 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 12/15/2022 |
4
| Nolan Garry Ph.D. (Director) has filed a Form 4 on Akoya Biosciences, Inc.|
Txns:
| Sold 100 shares
@ $13.25, valued at
$1.3k
|
|
| 12/06/2022 |
4
| Nolan Garry Ph.D. (Director) has filed a Form 4 on Akoya Biosciences, Inc.|
Txns:
| Sold 1,100 shares
@ $13.25, valued at
$14.6k
|
|
| 12/02/2022 |
4
| Nolan Garry Ph.D. (Director) has filed a Form 4 on Akoya Biosciences, Inc.|
Txns:
| Sold 5,000 shares
@ $13.3576, valued at
$66.8k
|
|
| 11/17/2022 |
4
| Nolan Garry Ph.D. (Director) has filed a Form 4 on Akoya Biosciences, Inc.|
Txns:
| Sold 300 shares
@ $13.2533, valued at
$4k
|
|
| 11/14/2022 |
4
| Nolan Garry Ph.D. (Director) has filed a Form 4 on Akoya Biosciences, Inc.|
Txns:
| Sold 3,810 shares
@ $13.3085, valued at
$50.7k
Sold 20,000 shares
@ $13.2929, valued at
$265.9k
Sold 600 shares
@ $13.2767, valued at
$8k
|
|
| 09/16/2022 |
4
| Nolan Garry Ph.D. (Director) has filed a Form 4 on Akoya Biosciences, Inc.|
Txns:
| Sold 8,305 shares
@ $13.2552, valued at
$110.1k
|
|
| 09/13/2022 |
4
| Nolan Garry Ph.D. (Director) has filed a Form 4 on Akoya Biosciences, Inc.|
Txns:
| Sold 22,191 shares
@ $13.3089, valued at
$295.3k
Sold 1,800 shares
@ $13.3023, valued at
$23.9k
|
|
| 06/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/21/2021 |
3/A
| Form 3/A - Initial statement of beneficial ownership of securities: [Amend] |
| 04/20/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|